Form 4: Intuitive Surgical Executive Exercises and Sells Stock Options Under 10b5-1 Plan
SEC Form 4 Filing
Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Summary
- Robert DeSantis, an executive at Intuitive Surgical, engaged in transactions involving the company's stock on August 12, 2024.
- He exercised non-qualified stock options to acquire 120 shares at prices of $229.39 and $304.67.
- Simultaneously, he sold 120 shares at a price of $464.76.
- These transactions were executed under a pre-arranged trading plan (Rule 10b5-1) set to expire on December 9, 2024.
- Following these transactions, DeSantis directly owns 5,506 shares of Intuitive Surgical common stock.
- He also holds options to purchase 3,591 shares at $229.39 and 3,591 shares at $304.67.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by an executive, and doesn't inherently convey positive or negative sentiment. It's a neutral reporting of facts.
Future Outlook
The executive's future transactions may be governed by the existing 10b5-1 trading plan, which expires on December 9, 2024.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's value and future prospects. The use of 10b5-1 plans allows insiders to trade without concerns about insider trading violations.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are standard across the medical device industry.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices of Intuitive Surgical's stock options are generally in line with industry norms for executive compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares involved.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Date from which option vesting is measured for one of the non-qualified stock options. |
| 08/10/2023 | Date from which option vesting is measured for one of the non-qualified stock options. |
| 08/12/2024 | Date of the stock option exercise and sale transactions. |
| 08/13/2024 | Date of signature on the Form 4 filing. |
| 12/09/2024 | Expiration date of the Rule 10b5-1 trading plan. |
| 02/27/2030 | Expiration date of one of the non-qualified stock options. |
| 08/09/2030 | Expiration date of one of the non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.